VBI Vaccines
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. VBI Vaccines's past years’ income statements indicate that its last revenue has increased compared to the previous period by 702% to $8,682,000. The net income raised on -$92,836,000 and profit margin reached -1069%. Total operating expenses were $49,496,000.
Profit Margin
| 2014 | 0 | -4.59M | |
|---|---|---|---|
| 2015 | 955K | -14.75M | -1545.03% |
| 2016 | 548K | -23.20M | -4234.49% |
| 2017 | 865K | -38.99M | -4508.09% |
| 2018 | 3.35M | -63.6M | -1895.68% |
| 2019 | 2.22M | -55.80M | -2512.61% |
| 2020 | 1.06M | -47.28M | -4456.74% |
| 2021 | 631K | -72.65M | -11513.47% |
| 2022 | 1.08M | -140.95M | -13026.89% |
| 2023 | 8.68M | -92.83M | -1069.29% |
VBIV Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 8.68M | 1.08M | 631K | 1.06M | 2.22M | 3.35M | 865K | 548K | 955K | 0 |
Cost of revenue | 14.49M | 11.27M | 10.77M | 9.16M | 7.90M | 4.50M | 5.19M | 3.67M | 3.75M | 0 |
Gross profit | -5.81M | -10.19M | -10.13M | -8.10M | -5.68M | -1.15M | -4.32M | -3.12M | -2.8M | 0 |
Operating exp. | ||||||||||
Research and development | 9.34M | 15.50M | 19.55M | 14.85M | 26.33M | 38.46M | 20.91M | 9.96M | 618K | 0 |
Selling and marketing | -1.99M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 49.49M | 71.62M | 57.89M | 35.51M | 40.42M | 59.25M | 32.95M | 21.72M | 8.16M | 5.29M |
Operating income | -55.31M | -81.82M | -68.03M | -43.61M | -52.39M | -60.40M | -37.28M | -24.85M | -8.83M | -5.14M |
Other income (expenses), net | -37.52M | -31.48M | -1.72M | -2.61M | -2.41M | -560K | -2.14M | 189K | -6.04M | 553.34K |
Income before tax | -92.83M | -113.30M | -69.75M | -46.23M | -54.81M | -63.6M | -39.42M | -24.98M | -14.88M | -4.59M |
Income tax expense | 1.82M | 27.64M | 2.89M | 1.05M | 992K | 560K | -431K | -1.78M | -129K | -840.31K |
Net income | -92.83M | -140.95M | -72.65M | -47.28M | -55.80M | -63.6M | -38.99M | -23.20M | -14.75M | -4.59M |
Earnings per share | ||||||||||
Basic EPS | -5.96 | -16.37 | -8.55 | -6.5 | -14.02 | -29.06 | -26.49 | -23.17 | -35.05 | -21.27 |
Diluted EPS | -5.96 | -16.37 | -8.55 | -6.5 | -14.02 | -29.06 | -26.49 | -23.17 | -35.05 | -21.27 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |